Home
Resources
Publications
Progestin-only Pills May Be a Better First-Line Treatment for Endometriosis Than Combined Estrogen-Progestin Contraceptive Pills

Progestin-only Pills May Be a Better First-Line Treatment for Endometriosis Than Combined Estrogen-Progestin Contraceptive Pills

Robert F Casper

Fertil Steril. 2017 Mar;107(3):533-536.

PMID: 28162779

Abstract:

For decades, combined estrogen-progestin oral contraceptive pills (OCPs) have been the first-line treatment for menstrual and pelvic pain associated with endometriosis without any clinical evidence of efficacy. Initial relief provided by OCPs is likely a result of improvement in primary dysmenorrhea. Biologic data and limited clinical evidence support a potential adverse effect of long-term use of OCPs on the progression of endometriosis. In contrast, there is randomized, controlled trial data to support the use of oral progestin-only treatment for pelvic pain associated with endometriosis and for suppressing the anatomic extent of endometriotic lesions. Both norethindrone acetate and dienogest have regulatory approval for treating endometriosis and may be better than OCPs as a first-line therapy.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP51989-B	Norethindrone acetate		51-98-9	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: